Search
Learn about the aspiring scientists who were celebrated this month for completing a unique summer research program.
MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer.
Memorial Sloan Kettering launched the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.
New research led by investigators at Memorial Sloan Kettering Cancer Center sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.
In our paper, published recently in the journal Expert Review of Hematology, we review the main challenges with current CD19-targeted CAR, obstacles to adopting CAR T cell therapy in solid tumors, and various strategies scientists are pursuing to overcome these issues.
MSK specialists are working to help reduce the stigma around lung cancer and smoking, helping to ensure that all patients get the best care.
More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
Learn why Black women face a higher risk of death from endometrial cancer, and about a new effort led by Dr. Carol Brown at Memorial Sloan Kettering Cancer Center to close the gap.
Ralph DeBerardinis, a professor at the University of Texas Southwestern, was one of the recipients of the 2021 Paul Marks Prize for Cancer Research.
Over the last decade radiation oncologists at Memorial Sloan Kettering have refined a technique that allows ablative doses of radiation to be delivered with low risk of toxicity to inoperable primary pancreas and liver tumors near critical organs.